MSF and co-authors argue in The Lancet HIV that the production of new COVID-19 drugs should not come at the expense of HIV drug supply.

Thousands of deaths from a fungal infection of the brain called cryptococcal meningitis (CM) could potentially be averted every year in South Africa if an antifungal medicine called flucytosine is widely available.

It is unacceptable that people living with HIV are still dying because the tests, treatment and care for life-threatening infections are not available.

MSF spotlights the lack of access to antibiotics to address antimicrobial resistance (AMR) in low- and middle-income countries (LMICs)

In this MSF commentary, although progress has been made in reducing the global burden of visceral leishmaniasis ('kala azar'), threats loom on the horizon.

The race is on to develop a vaccine to protect against COVID-19. Germany, the United States, the European Union and others have collectively committed more than a billion dollars.

Shortages of first-line antibiotics, which are essential to treat a wide range of common infections, are a major public health threat

This week in Korea, the 16 countries of the Regional Comprehensive Economic Partnership (RCEP) agreement are meeting in Incheon for the 20th round of negotiations on this multilateral trade deal.

Manila is set to host the 18th round of the multilateral trade deal — the Regional Comprehensive Economic Partnership (RCEP) that encompasses 50% of the global population.

Japan, China, South Korea, India, Australia, and New Zealand together with the 10 ASEAN countries, which comprise the Regional Comprehensive Economic Partnership (RCEP), are meeting in Kobe this week to continue trade negotiations that ...

Shailly Gupta, Deputy Head, MSF Access Campaign (India) emphaises the need to ensure availability of affordable medicines within public health programmes, which is the need of the hour

Today millions of people living with HIV in South-East Asia are receiving treatment and leading healthy lives thanks to affordable generic antiretroviral (ARVs) medicines.